Tranexamic Acid Injection, Solution
Product Images NDC 25021-415

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 25021-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tra1j 0000 01)

Chemical structure of tranexamic acid, showing its molecular arrangement with an amino group, a cyclohexane ring, and a carboxylic acid group.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Tra1j 0000 02)

Label for Tranexamic Acid Injection, USP, 100 mg/mL (1,000 mg per 10 mL) in a 10 mL single-dose vial for intravenous use. The label notes it is nonpyrogenic and preservative-free, manufactured for Sagent Pharmaceuticals, with storage instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.